Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −30 vs. previous quarter
- 319
- 13F valueReported value at the end of Q2 2026
- $2.54B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Superinvestors holding PBH, Q2 2026
1 superinvestor reports holding Prestige Consumer Healthcare Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Maverick Capital
Lee Ainslie
<0.1%
Prestige Consumer Healthcare Inc.'s share of the portfolio
- Shares
- 50,975
- Value
- $2.41M
Latest insider trades
Open-market purchases and sales by Prestige Consumer Healthcare Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 (view filing) | May 11 | 1 day | Zerillo JeffreySenior VP Operations | SSaleCommon Stock, par value $0.01 per share | −351 | $52.28 | −$18.4K | −0.8%41.8K after | 10b5-1 |
| May 11, 2026 (view filing) | May 7 | 4 days | Zerillo JeffreySenior VP Operations | SSaleCommon Stock, par value $0.01 per share | −305 | $54.36 | −$16.6K | −0.7%42.2K after | 10b5-1 |
| May 7, 2026 (view filing) | May 5 | 2 days | Zerillo JeffreySenior VP Operations | SSaleCommon Stock, par value $0.01 per share | −1.21K | $54.99 | −$66.4K | −2.7%42.8K after | |
| May 6, 2026 (view filing) | May 5 | 1 day | Zerillo JeffreySenior VP Operations | SSaleCommon Stock, par value $0.01 per share | −346 | $55.32 | −$19.1K | −0.8%44.3K after | 10b5-1 |
| Feb 13, 2026 (view filing) | Feb 11 | 2 days | Zerillo JeffreySenior VP Operations | SSaleCommon Stock, par value $0.01 per share | −1.00K | $65.93 | −$65.9K | −2.4%41.0K after | |
| Dec 2, 2025 (view filing) | Nov 28-Dec 1 | 4 days | Zerillo JeffreySenior VP Operations | SSaleCommon Stock, par value $0.01 per share | −1.00K | $60.00 | −$60.0K | −2.3%42.0K after | 2 lots10b5-1 |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | Byom John EDirector | SSaleCommon Stock, par value $0.01 per share | −3.00K | $59.35 | −$178.1K | −5.5%51.6K after | |
| Mar 12, 2025 (view filing) | Mar 10 | 2 days | Fritz Mary BethSVP Quality & Regulatory | SSaleCommon Stock, par value $0.01 per share | −1.68K | $90.00 | −$151.0K | −8.9%17.2K after | 10b5-1 |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Fritz Mary BethSVP Quality & Regulatory | SSaleCommon Stock, par value $0.01 per share | −6.30K | $85.39 | −$537.7K | −25.1%18.8K after | 10b5-1 |
| Feb 13, 2025 (view filing) | Feb 11 | 2 days | Mekhail AdelEVP, Marketing & Sales | SSaleCommon Stock, par value $0.01 per share | −11.1K | $86.55 | −$959.3K | −37.6%18.4K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Prestige Consumer Healthcare Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,831,333 | $370.2M | 0.01% | +442,843+6.0% | Added |
| Ariel Investments, LLC | 4,868,711 | $230.1M | 2.29% | +594,385+13.9% | Added |
| Vanguard Portfolio Management LLC | 2,825,340 | $133.6M | 0.01% | +21,512+0.8% | Added |
| Dimensional Fund Advisors LP | 2,661,291 | $125.8M | 0.02% | −11,486−0.4% | Reduced |
| Fuller & Thaler Asset Management, Inc. | 2,331,821 | $110.2M | 0.30% | +2,331,821 | New |
| Vanguard Capital Management LLC | 2,136,944 | $101.0M | 0.00% | +43,951+2.1% | Added |
| State Street Corp | 2,116,513 | $100.0M | 0.00% | +145,532+7.4% | Added |
| Brandes Investment Partners, LP | 2,051,060 | $97.0M | 0.68% | +1,196,941+140.1% | Added |
| Kayne Anderson Rudnick Investment Management LLC | 1,872,023 | $88.5M | 0.27% | −330,583−15.0% | Reduced |
| Geode Capital Management, LLC | 1,571,742 | $74.3M | 0.00% | +111,707+7.7% | Added |